- Home
- GRDN vs TXG Comparison
GRDN vs TXG Comparison
Compare GRDN & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRDN
- TXG
- Stock Information
- Founded
- GRDN 2004
- TXG 2012
- Country
- GRDN United States
- TXG United States
- Employees
- GRDN N/A
- TXG N/A
- Industry
- GRDN Retail-Drug Stores and Proprietary Stores
- TXG Biotechnology: Laboratory Analytical Instruments
- Sector
- GRDN Consumer Staples
- TXG Industrials
- Exchange
- GRDN Nasdaq
- TXG Nasdaq
- Market Cap
- GRDN 1.8B
- TXG 1.7B
- IPO Year
- GRDN 2024
- TXG 2019
- Fundamental
- Price
- GRDN $30.29
- TXG $13.06
- Analyst Decision
- GRDN Strong Buy
- TXG Buy
- Analyst Count
- GRDN 2
- TXG 12
- Target Price
- GRDN $24.50
- TXG $13.54
- AVG Volume (30 Days)
- GRDN 313.2K
- TXG 2.4M
- Earning Date
- GRDN 11-11-2025
- TXG 10-28-2025
- Dividend Yield
- GRDN N/A
- TXG N/A
- EPS Growth
- GRDN N/A
- TXG N/A
- EPS
- GRDN N/A
- TXG N/A
- Revenue
- GRDN $1,326,604,000.00
- TXG $644,466,000.00
- Revenue This Year
- GRDN $16.17
- TXG $1.75
- Revenue Next Year
- GRDN $2.31
- TXG N/A
- P/E Ratio
- GRDN N/A
- TXG N/A
- Revenue Growth
- GRDN 18.53
- TXG 2.02
- 52 Week Low
- GRDN $14.16
- TXG $6.78
- 52 Week High
- GRDN $30.27
- TXG $24.38
- Technical
- Relative Strength Index (RSI)
- GRDN 82.92
- TXG 46.58
- Support Level
- GRDN $27.35
- TXG $12.97
- Resistance Level
- GRDN $28.98
- TXG $14.10
- Average True Range (ATR)
- GRDN 1.00
- TXG 0.61
- MACD
- GRDN 0.21
- TXG -0.14
- Stochastic Oscillator
- GRDN 99.81
- TXG 30.89
About GRDN Guardian Pharmacy Services Inc. Class A Common Stock
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).